Salud financiera de hoja de balance de Medy-Tox

Salud financiera controles de criterios 6/6

Medy-Tox tiene un patrimonio de accionistas total de ₩498.6B y una deuda total de ₩80.9B, lo que sitúa su ratio deuda-patrimonio en 16.2%. Sus activos y pasivos totales son ₩625.5B y ₩126.9B respectivamente. El BAIT de Medy-Tox es de ₩21.8B, por lo que su ratio de cobertura de intereses es de 15.2. Tiene efectivo e inversiones a corto plazo que ascienden a ₩27.7B.

Información clave

16.2%

Ratio deuda-patrimonio

₩80.91b

Deuda

Ratio de cobertura de intereses	15.2x
Efectivo	₩27.70b
Patrimonio	₩498.58b
Total pasivo	₩126.92b
Activos totales	₩625.49b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Lacklustre Performance Is Driving Medy-Tox Inc.'s (KOSDAQ:086900) 27% Price Drop

Nov 18

Medy-Tox Inc. (KOSDAQ:086900) Surges 37% Yet Its Low P/S Is No Reason For Excitement

Jul 19

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₩161.2B) de A086900 superan a sus pasivos a corto plazo (₩119.0B).

Pasivo a largo plazo: Los activos a corto plazo de A086900 (₩161.2B) superan a sus pasivos a largo plazo (₩7.9B).

Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (10.7%) de A086900 se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de A086900 ha pasado de 34.9% a 16.2% en los últimos 5 años.

Cobertura de la deuda: La deuda de A086900 está bien cubierta por el flujo de caja operativo (24.8%).

Cobertura de intereses: Los pagos de intereses de la deuda de A086900 están bien cubiertos por el BAIT (15.2x cobertura).

Salud financiera de hoja de balance de Medy-Tox

Salud financiera controles de criterios 6/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

Lacklustre Performance Is Driving Medy-Tox Inc.'s (KOSDAQ:086900) 27% Price Drop

Consensus EPS estimates fall by 35%

Price target decreased by 20% to ₩222,000

Price target decreased by 11% to ₩245,000

Price target increased by 7.5% to ₩288,000

Medy-Tox Inc. (KOSDAQ:086900) Surges 37% Yet Its Low P/S Is No Reason For Excitement

New minor risk - Share price stability

Consensus EPS estimates fall by 46%

Medy-Tox's (KOSDAQ:086900) Anemic Earnings Might Be Worse Than You Think

Price target decreased by 7.0% to ₩296,000

Medy-Tox Inc., Annual General Meeting, Mar 29, 2024

Medy-Tox Inc., Annual General Meeting, Mar 29, 2024

Medy-Tox Inc., Annual General Meeting, Mar 29, 2024

Medy-Tox Inc.'s (KOSDAQ:086900) Prospects Need A Boost To Lift Shares

Consensus EPS estimates increase by 14%

New minor risk - Profit margin trend

Consensus EPS estimates fall by 33%, revenue upgraded

Upcoming dividend of ₩952 per share at 0.4% yield

Investor sentiment improves as stock rises 23%

Price target increased by 16% to ₩330,000

Consensus EPS estimates increase by 29%

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 17%

Price target increased by 28% to ₩177,429

Investor sentiment improves as stock rises 27%

Consensus forecasts updated

Now 20% undervalued

Less than half of directors are independent

Consensus EPS estimates increase by 71%

Investor sentiment improved over the past week

Consensus forecasts updated

Medy-Tox Inc.(KOSDAQ:A086900) dropped from FTSE All-World Index (USD)

Consensus forecasts updated

Investor sentiment improved over the past week

Consensus forecasts updated

Consensus forecasts updated

Now 22% undervalued after recent price drop

Now 21% undervalued

Consensus forecasts updated

Less than half of directors are independent

Now 20% undervalued after recent price drop

Consensus forecasts updated

Price target decreased to ₩152,333

Price target decreased to ₩165,429

Upcoming dividend of ₩1,000 per share

Price target decreased to ₩207,250

Investor sentiment deteriorated over the past week

Consensus EPS estimates increase to ₩12,541

Price target increased to ₩246,362

Investor sentiment improved over the past week

Medy-Tox Inc. announced that it has received KRW 64.99993078 billion in funding

Medy-Tox Inc. announced that it expects to receive KRW 64.99993078 billion in funding

Tread With Caution Around Medy-Tox Inc.'s (KOSDAQ:086900) 0.4% Dividend Yield

Price target raised to ₩221,214

A Look At Medy-Tox's (KOSDAQ:086900) Share Price Returns

New 90-day low: ₩130,900

Read This Before Buying Medy-Tox Inc. (KOSDAQ:086900) For Its Dividend

New 90-day low: ₩163,500

Price target lowered to ₩169,749

Upcoming Dividend of ₩777 Per Share

New 90-day high - ₩272,900

Price target raised to ₩199,900

Price target lowered to ₩179,200

Analysts update estimates

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera